MTM Respiratory Disease Management 3

Question 1

A patient prescribed an inhaled corticosteroid (ICS) for asthma asks how to prevent oral candidiasis. What is the MOST effective counseling point?

Accepted Answer

Rinse the mouth and gargle with water after each use

Answer

Rinsing the mouth and gargling after ICS use removes residual drug from the oropharynx, significantly reducing the risk of oral candidiasis.

Question 2

Which respiratory medication requires monitoring of serum drug levels due to its narrow therapeutic index?

Accepted Answer

Theophylline

Answer

Theophylline has a narrow therapeutic index (target 5-15 mcg/mL) and requires regular serum level monitoring to ensure efficacy and avoid toxicity.

Question 3

A COPD patient on triple therapy reports increased dyspnea and purulent yellow-green sputum for 3 days. This presentation is MOST consistent with:

Accepted Answer

Acute COPD exacerbation

Answer

Increased dyspnea with change in sputum character (volume or purulence) beyond normal day-to-day variation is the hallmark of an acute COPD exacerbation.

Question 4

When counseling a patient about proper dry powder inhaler (DPI) technique, the pharmacist should emphasize:

Accepted Answer

Rapid, forceful inhalation through the device

Answer

DPIs require rapid, forceful inhalation to generate sufficient turbulent airflow to disaggregate and deliver the powder to the lower airways.

Question 5

Which biologic agent targets the IL-4/IL-13 pathway and is FDA-approved for moderate-to-severe eosinophilic or OCS-dependent asthma?

Accepted Answer

Dupilumab (anti-IL-4Rα)

Answer

Dupilumab blocks the IL-4Rα receptor, inhibiting both IL-4 and IL-13 signaling, and is approved for moderate-to-severe asthma and other type 2 inflammatory conditions.

(MTM) Medication Therapy Management Certification for Pharmacists Practice Test

(MTM) Medication Therapy Management Certification for Pharmacists Practice Test

MTM Respiratory Disease Management 3